U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Flagship VentureLabs IV, LLC (0001642578)
State location: MA | State of Inc.: DE | Fiscal Year End: 1231
Business Address
55 CAMBRIDGE PARKWAY, 8TH FLOOR
CAMBRIDGE MA 02143
617-868-1888
Mailing Address
55 CAMBRIDGE PARKWAY, 8TH FLOOR
CAMBRIDGE MA 02143
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Axcella Health Inc. 0001633070 2019-05-08 10 percent owner
Kaleido Biosciences, Inc. 0001751299 2019-02-27 10 percent owner
Moderna, Inc. 0001682852 2018-12-07 10 percent owner
Rubius Therapeutics, Inc. 0001709401 2018-07-17 10 percent owner
Evelo Biosciences, Inc. 0001694665 2018-05-08 10 percent owner
Syros Pharmaceuticals, Inc. 0001556263 2017-08-17 10 percent owner
Seres Therapeutics, Inc. 0001609809 2016-05-25 10 percent owner


Items 1 - 0

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016